No Dallas, But, Maybe, Dallas Buyer's Club
In an October 18, 1992, Dallas Morning News story I cannot find online, Bill Minutaglio wrote a farewell to Ron Woodroof, who Minutaglio described as a "combative ex-electrician who had achieved some measure of notoriety around the country as a smuggler who had never been caught." Woodroof was indeed a well-known peddler of illegal narcotics -- specifically, non-government-approved drugs that Dallas AIDS patients were using to stay alive long after doctors had told them to go home and die. Woodroof's story was a particularly compelling one: A heterosexual, homphobic electrician, he contracted HIV in 1980, was diagnosed with AIDS in 1986 and eventually went on to found the famous Dallas Buyer's Club through which AIDS patients bought their life-prolonging meds.
For several years, a screenplay about Woodroof has been circulating throughout Hollywood: In 2002, a script by Guillermo Arriaga (Babel, 21 Grams) was sold to Universal. (Arriaga had reworked an earlier screeplay by Craig Borten and Melissa Wallack.) Attached to direct was Marc Forster (Monster's Ball, Finding Neverland), and, it says way back here, "Brad Pitt has showed some interest in the lead role."
Well, if the latest issue of Time is any indication, the years-in-the-making project is a little closer to go than stop-and-wait: In a story about the Holy Trinity of hot Mexican filmmakers -- Babel's Alejandro Gonz�lez I��rritu, Pan's Labyrinth's Guillermo del Toro and Children of Men's Alfonso Cuar�n -- Richard Corless writes: "Arriaga has written a true-life AIDS drama, The Dallas Buyer's Club, which is to star and be produced by a member of the Babel ensemble: Brad Pitt." The Internet Movie Database has it listed as a 2008 release -- and it also has a comment from someone insisting this is the sequel to Fight Club. So, believe what you must. --Robert Wilonsky
Get the This Week's Top Stories Newsletter
Every week we collect the latest news, music and arts stories — along with film and food reviews and the best things to do this week — so that you’ll never miss Observer's biggest stories.